Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
Cristina R. Ferrone(Cedars-Sinai Medical Center), Carlos Fernández‐del Castillo(Massachusetts General Hospital), David T. Ting(Massachusetts General Hospital), Jason E. Faris(Royal Marsden NHS Foundation Trust), Erin McDonnell(Harvard University), Giovanni Marchegiani(University of Padua), Vikram Deshpande(Beth Israel Deaconess Medical Center), Theodore S. Hong(Massachusetts General Hospital), Keith D. Lillemoe(Harvard University), Lipika Goyal(Stanford Medicine), Janet E. Murphy(Harvard University), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Eunice L. Kwak(Harvard University), Daniela Santos, Andrew L. Warshaw(Harvard University), Jill N. Allen(Harvard University), Francesco Sabbatino(University of Salerno)
Cited by 841
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k